E-Clinical Solution Software Market will reach an estimated valuation of US$6,515.3 million in 2020

The Global e-clinical solutions market was estimated at US$3,005 million in 2014. A recent report published by Transparency Market Research studies the most recent statistical nuances to evaluate the present trends and growth trajectory of the global e-clinical solutions market. The report is titled “E-Clinical Solution Software Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020” and is available on the website for sale. The report forecasts that the global e-clinical solution software market will reach an estimated valuation of US$6,515.3 million in 2020, exhibiting an impressive 13.8% CAGR. Rising incidence of genetic disorders and lifestyle diseases has been cited across the Middle East and North African countries, increasing clinical trials in these regions. The pharmaceutical industry is under pressure to reduce the gestation period of clinical trials in order to raise the productivity of drugs, which is also expected to boost the market for e-clinical solutions software. Additionally, rising demand from end users such as clinical research organizations (CRO), healthcare providers, and the pharmaceutical industry has ensured increased acceptance of e-clinical solutions software. 

“Enhanced investment in clinical trials and research and development efforts in pharmaceutical and lifestyle industry is propelling the e-clinical solution software market”, said a lead TMR analyst.While the demand for e-clinical software solutions is ascending, high cost incurred on the implementation of the process, inadequate skilled manpower, and the long time taken for approval are major concerns for the market. Before commencing a clinical trial, the biopharmaceutical and pharmaceutical companies need formal approval from competent authorities in respective countries. This also hampers the progress of the trial. Lack of high-speed broadband, especially in remote areas, can also inhibit the e-clinical solution software market. 

The report segments the global e-clinical solution software market into North America, Europe, Asia, and Rest of the World (RoW). Among these regions, North America held the largest share in the global e-clinical software solutions market. The e-clinical solution software market in North America was valued at US$1,773.9 million in 2014. Demonstrating a CAGR of 12.6%, the market is expected to reach US$3,622.5 million in 2020.However, as a consequence of stringent regulatory norms in the region, its share in the global clinical trials market is likely to reduce over the period. Owing to this, leading players in the clinical solution software market are shifting their focus to leading economies in Asia such as India and China. Asia, therefore, will emerge as the fastest growing e-clinical solution software market between 2014 and 2020. In terms of mode of delivery, the report has cited cloud-based e-clinical solution software as the fastest growing segment, and CROs are identified as the leading segment in terms of end users. 

 

Browse Full E-Clinical Solution Software Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 Research Report With Complete TOC @ http://www.transparencymarketresearch.com/e-clinical-solution-software-market.html

 

E-Clinical Solution Software Market Segmentation, by Mode of Delivery: